Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Sold Out, 2022 Q4

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q4 2022: Stock VERONA PHARMA PLC; Country of operation —; Class SPONSORED ADS; Shares before 695,260.
  • Q4 2022: Stock POLESTAR AUTOMOTIVE HLDG UK; Country of operation —; Class ADS A; Shares before 1,007,340.
  • Q4 2022: Stock RENREN INC; Country of operation —; Class SPONSORED ADS; Shares before 7,744.
  • Q4 2022: Stock FOUR SEASONS ED CAYMAN INC; Country of operation —; Class SPON ADS; Shares before 11,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2022VERONA PHARMA PLC
CUSIP 925050106
—SPONSORED ADS695,2600-695,260$7,106$0-$7,1062023-02-14
Q4 2022POLESTAR AUTOMOTIVE HLDG UK
CUSIP 731105201
—ADS A1,007,3400-1,007,340$5,097$0-$5,0972023-02-14
Q4 2022RENREN INC
CUSIP 759892300
—SPONSORED ADS7,7440-7,744$229$0-$2292023-02-14
Q4 2022FOUR SEASONS ED CAYMAN INC
CUSIP 35101A309
—SPON ADS11,0000-11,000$154$0-$1542023-02-14
Q4 2022SPARK NETWORKS SE
CUSIP 846517100
—SPONSORED ADS55,3090-55,309$106$0-$1062023-02-14
Q4 2022MORPHOSYS AG
CUSIP 617760202
—SPONSORED ADS20,0490-20,049$101$0-$1012023-02-14
Q4 2022ONECONNECT FINL TECHNOLOGY C
CUSIP 68248T105
—SPONSORED ADS116,9570-116,957$84$0-$842023-02-14
Q4 2022RENALYTIX PLC
CUSIP 75973T101
—ADS64,0690-64,069$82$0-$822023-02-14
Q4 2022BURNING ROCK BIOTECH LTD
CUSIP 12233L107
—SPONSORED ADS26,0060-26,006$63$0-$632023-02-14
Q4 2022CHEMOMAB THERAPEUTICS LTD
CUSIP 16385C104
—SPONSORED ADS21,2260-21,226$53$0-$532023-02-14
Q4 2022BANCO BRADESCO S A
CUSIP 059460402
—SPONSORED ADR17,0120-17,012$51$0-$512023-02-14
Q4 2022BIT MINING LIMITED
CUSIP 055474100
—SPON ADR REP A151,3230-151,323$42$0-$422023-02-14
Q4 2022MECHEL PAO
CUSIP 583840608
—SPONSORED ADR NE41,1530-41,153$34$0-$342023-02-14
Q4 2022UXIN LTD
CUSIP 91818X108
—ADS43,6830-43,683$26$0-$262023-02-14
Q4 2022AKSO HEALTH GROUP
CUSIP 98422P108
—ADS23,2090-23,209$21$0-$212023-02-14
Q4 2022AESTHETIC MED INTL HLDG GR L
CUSIP 00809M104
—ADS12,2870-12,287$21$0-$212023-02-14
Q4 2022WISEKEY INTERNATIONAL HLDS L
CUSIP 97727L309
—SPON ADS10,6410-10,641$17$0-$172023-02-14
Q4 2022ADVANCED HUMAN IMAGING LTD
CUSIP 00777C104
—SPON ADS29,4750-29,475$16$0-$162023-02-14
Q4 2022PINTEC TECHNOLOGY HLDGS LTD
CUSIP 72352G206
—SPONSORED ADS52,7380-52,738$14$0-$142023-02-14
Q4 2022ICLICK INTERACTIVE ASIA GROU
CUSIP 45113Y104
—SPONSORED ADR38,5960-38,596$14$0-$142023-02-14
Q4 2022AMTD IDEA GROUP
CUSIP 00180G106
—SPONSORED ADS10,8250-10,825$13$0-$132023-02-14
Q4 2022MEDIGUS LTD
CUSIP 58471G300
—SPONSORED ADS15,2140-15,214$8$0-$82023-02-14